Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx® BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain More
Two Lawson and four Western projects are one step closer in moving their research towards commercialization with awards from the Western Innovation Fund (WIF). More
Published this week in the Canadian Medical Association Journal, Dr. William Clark, Scientist at Lawson Health Research Institute, has found that excessive fluid intake can lead to proteinuria, or protein in the urine. More